Published in Experientia on September 15, 1975
Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons. J Med Chem (2010) 0.90
Early detection of rifampin in human nerve tissue after an oral dose of 600 milligrams. Antimicrob Agents Chemother (1995) 0.75
Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med (1969) 6.16
Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA. Proc Natl Acad Sci U S A (1969) 5.78
Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J Virol (1970) 4.73
Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis. Proc Natl Acad Sci U S A (1976) 4.62
Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol (1996) 4.50
A unique form of terminal redundancy in adenovirus DNA molecules. Proc Natl Acad Sci U S A (1972) 4.18
Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol (1981) 3.72
Nucleic acid from an adeno-associated virus: chemical and physical studies. Proc Natl Acad Sci U S A (1966) 3.55
Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem (1971) 3.34
Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A (1985) 3.31
RNA production in adenovirus-infected KB cells. Virology (1965) 3.06
Structural proteins of adenovirus-associated viruses. J Virol (1971) 3.03
Adenosine 3',5'-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex. J Biol Chem (1967) 3.03
Self-complementarity of terminal sequences within plus or minus strands of adenovirus-associated virus DNA. Proc Natl Acad Sci U S A (1973) 2.96
Nucleic acid homology studies of adenovirus type 7-SV40 interactions. Proc Natl Acad Sci U S A (1966) 2.86
Adenovirus-associated virus multiplication. VII. Helper requirement for viral deoxyribonucleic acid and ribonucleic acid synthesis. J Virol (1972) 2.74
Simian virus 40 integration site in an adenovirus 7-simian virus 40 hybrid DNA molecule. Proc Natl Acad Sci U S A (1971) 2.64
Training in leprosy: does the current strategy need revision? Lepr Rev (1995) 2.59
Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine. Br J Clin Pharmacol (1975) 2.49
Characterization of adenovirus-associated virus-induced polypeptides in KB cells. J Virol (1978) 2.40
Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication. Br Med J (1969) 2.08
Abnormal function of potassium channels in platelets of patients with Alzheimer's disease. Lancet (1998) 2.07
Adenovirus-associated virus multiplication. VI. Base compostion of the deoxyribonucleic acid strand species and strand-specific in vivo transcription. J Virol (1971) 2.05
Mechanism of the antidepressant action of electroconvulsive therapy. Lancet (1978) 2.03
Genetic relatedness among mycoplasmas as determined by nucleic acid homology. J Bacteriol (1966) 2.00
Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor. Br J Pharmacol (1971) 1.90
Locations of adenovirus genes required for the replication of adenovirus-associated virus. Proc Natl Acad Sci U S A (1981) 1.90
Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript. J Virol (1988) 1.89
Adenovirus-associated virus multiplication. IX. Extent of transcription of the viral genome in vivo. J Virol (1972) 1.87
Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke (2000) 1.87
Propagation and purification of high-titer human cytomegalovirus. Appl Microbiol (1971) 1.85
Adeno-associated virus proteins: origin of the capsid components. J Virol (1984) 1.84
Misuse of temazepam. BMJ (1991) 1.82
Separate helper functions provided by adenovirus for adenovirus-associated virus multiplication. Nat New Biol (1973) 1.82
Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature (1976) 1.77
Genetic relatedness studies with adenovirus-associated viruses. J Virol (1968) 1.76
Mapping of base sequence heterologies between genomes from different adenovirus serotypes. Virology (1973) 1.71
Adenovirus-associated virus multiplication. 8. Analysis of in vivo transcription induced by complete or partial helper viruses. J Virol (1972) 1.65
Transcription in vivo of a defective parvovirus: sedimentation and electrophoretic analysis of RNA synthesized by adenovirus-associated virus and its helper adenovirus. Virology (1974) 1.57
Measurement of specific [3H]-ouabain binding to different types of human leucocytes. Br J Clin Pharmacol (1984) 1.56
DNA-minus temperature-sensitive mutants of adenovirus type 5 help adenovirus-associated virus replication. J Virol (1975) 1.54
Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs. Br J Pharmacol (1976) 1.48
Helper-dependent infectious deoxyribonucleic acid from adenovirus-associated virus. J Virol (1968) 1.45
Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response. Br J Clin Pharmacol (1977) 1.44
Leprosy control and the implementation of multiple drug therapy: to what extent can the operational strategy be simplified for primary health care? Lepr Rev (1992) 1.43
Educational material for the patient with leprosy. Lepr Rev (1989) 1.39
A re-appraisal of clinical and bacteriological criteria in the implementation of multiple drug therapy for leprosy control programmes and proposals for their better use. Lepr Rev (1990) 1.39
The use of xylene (xylol) in medical laboratories. Lepr Rev (1989) 1.39
Human cytomegalovirus completely helps adeno-associated virus replication. Virology (1985) 1.39
Proceedings: An isolated perfused rat brain--some histological and metabolic features. Clin Sci Mol Med (1974) 1.38
Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour. Neuropharmacology (1976) 1.35
5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol (1989) 1.35
Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology (Berl) (1977) 1.35
Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med (1978) 1.34
Cation transport functions in vitro in patients with untreated essential hypertension: a comparison of erythrocytes and leucocytes. Clin Sci (Lond) (1985) 1.34
Structural proteins of adenovirus-associated virus: subspecies and their relatedness. J Virol (1983) 1.34
Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites. Br J Pharmacol (1975) 1.31
Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes. J Neurol Neurosurg Psychiatry (1975) 1.28
The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. Neuropharmacology (1974) 1.26
(-)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system. Nature (1976) 1.26
Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA. Virology (1989) 1.23
Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation. Br J Clin Pharmacol (1979) 1.23
Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: effects on regulation of synthesis and biological activity. J Virol (1994) 1.19
A sensitive radioenzymatic assay for adrenaline and noradrenaline in plasma. Br J Clin Pharmacol (1977) 1.17
The epidemiology of carcinoid tumours in England and Scotland. Br J Cancer (1994) 1.15
A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]-dihydroergocryptine. J Auton Pharmacol (1983) 1.15
Adeno-associated virus helper activity of adenovirus DNA binding protein. J Virol (1982) 1.14
The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition. Br J Pharmacol (1974) 1.13
The effect of diphenylhydantoin on brain 5-hydroxytryptamine metabolism and function. Neuropharmacology (1975) 1.13
Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone. Neuropharmacology (1983) 1.12
Psittacosis masquerading as rheumatic fever. Br Med J (1978) 1.12
The relationship between plasma catecholamines and severity of injury in man. J Trauma (1984) 1.11
Lepromatous leprosy presenting with polyarthritis, myositis, and immune-complex glomerulonephritis. Br Med J (1975) 1.11
Abnormal regulation of adenosine 3',5'-monophosphate and corticosterone formation in an adrenocortical carcinoma. J Clin Invest (1969) 1.11
Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: relevance to the mechanism of the antidepressive effect of electroconvulsive therapy. Psychopharmacology (Berl) (1979) 1.11
Transcription of adenovirus-associated virus RNA in isolated KB cell nuclei. Virology (1978) 1.10
Enhancement of specific [3H]ouabain binding and ouabain sensitive 86rubidium influx in intact human lymphocytes by a dialysable factor in human and fetal calf serum. Clin Sci (Lond) (1987) 1.10
Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock. Br Heart J (1979) 1.10
The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy. Br J Clin Pharmacol (1979) 1.10
Platelet aggregation and chlorpromazine therapy. Br J Clin Pharmacol (1978) 1.10
Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery (1995) 1.09
Quantitation of the granuloma fraction in leprosy skin biopsies by planimetry. Int J Lepr Other Mycobact Dis (1985) 1.08
The effects of serum, lithium, ethacrynic acid, and a low external concentration of potassium on specific [3H]-ouabain binding to human lymphocytes after incubation for 3 days. Br J Clin Pharmacol (1986) 1.07
Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol (1982) 1.07
The contrasting actions of TRH and cycloheximide in altering the effects of centrally acting drugs: evidence for the non-involvement of dopamine sensitive adenylate cyclase. Neuropharmacology (1976) 1.05
Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli. Lepr Rev (1974) 1.05
Tryptophan hydroxylation in brain. Biochem Biophys Res Commun (1964) 1.04
The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects. Biochem J (1972) 1.04
Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1976) 1.04
The biosynthesis of 5-hydroxytryptamine in brain. Biochem J (1967) 1.03
Altered distribution of digoxin in renal failure--a cause of digoxin toxicity? Br J Clin Pharmacol (1976) 1.03
Mechanism of host restriction of adenovirus-associated virus replication in African green monkey kidney cells. J Gen Virol (1979) 1.03
An evaluation of the contribution of the Swedish International Development Authority (SIDA) to leprosy control in India based on the implementation of multiple drug therapy (MDT) 1981-1993. Indian J Lepr (1996) 1.02
Adeno-associated virus DNA replication is induced by genes that are essential for HSV-1 DNA synthesis. Virology (1990) 1.01
A novel signature mutation for oxidative damage resembles a mutational pattern found commonly in human cancers. Cancer Res (1999) 1.00
The carcinoid syndrome. Am J Cardiol (1968) 1.00